Which statement best describes the clinical utility of plasma homocysteine?

Which statement best describes the clinical utility of plasma homocysteine?

• A. High levels are associated with better cardiovascular health
• B. High plasma levels are linked to atherosclerosis and increased risk of thrombosis
• C. Homocysteine has no impact on coronary artery disease
• D. Low levels are a marker for diabetes

Answer: (B)

High plasma levels of homocysteine have been extensively studied and are associated with increased risk factors for cardiovascular diseases, including atherosclerosis and thrombosis. Elevated homocysteine levels can lead to endothelial dysfunction, which is a precursor for atherosclerosis, and they may enhance the thrombogenic potential by promoting clot formation. As a result, individuals with high homocysteine levels are often found to have an increased risk of cardiovascular events. This relationship emphasizes the role of homocysteine as a potential biomarker for assessing cardiovascular health and the risk of related diseases, underscoring its clinical relevance in monitoring and managing cardiovascular risk factors.

High plasma levels of homocysteine have been extensively studied and are associated with increased risk factors for cardiovascular diseases, including atherosclerosis and thrombosis. Elevated homocysteine levels can lead to endothelial dysfunction, which is a precursor for atherosclerosis, and they may enhance the thrombogenic potential by promoting clot formation. As a result, individuals with high homocysteine levels are often found to have an increased risk of cardiovascular events. This relationship emphasizes the role of homocysteine as a potential biomarker for assessing cardiovascular health and the risk of related diseases, underscoring its clinical relevance in monitoring and managing cardiovascular risk factors.